Insights from AHS 2026, including anticipated presentations, key takeaways, and how new research in migraine treatment will affect patient care.
3d
Johnson & Johnson (JNJ) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
Bernstein 42nd Annual Strategic Decisions Conference May 27, 2026 11:00 AM EDTCompany ParticipantsJoaquin Duato - CEO ...
WHAT: Researchers from the Johns Hopkins Kimmel Cancer Center will present new research findings and receive honors and ...
The event is Nov. 11-12 in Cleveland and will feature specialized exhibitions, including Plastics Recycling World Expo, ...
Over the next two days, the Robotics Summit & Expo will bring thousands of attendees and hundreds of exhibitors to Boston.
A new class of migraine treatment in clinical trials, the genetics of a potentially new headache disorder, and the effects of GLP-1 medications on migraine in the clinic-these are just some of the ...
Slowing the loss of ambulation in patients with Duchenne muscular dystrophy (DMD) may also mitigate worsening disease burden and overall function, according to a pair of posters presented at ISPOR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results